PCSK9 and coronary artery disorder: Similarly, of 9524 white individuals, about 1 in 30 had a heterozygous sequence variation (PCSK946L) in PCSK9 that was associated with 15% lower LDL-cholesterol levels and a halving in the risk of CHD (adjusted HR 0.50; 95% CI 0.32, 0.79).